acetylcysteine has been researched along with enalaprilat anhydrous in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chin, SA; Fawcett, JP; Walker, RJ | 1 |
Goldschmidt, JE; Tallarida, RJ | 1 |
Lawson, DL; Mehta, JL; Mehta, P; Nichols, WW | 1 |
Mollace, V; Salvemini, D; Sessa, WC; Vane, JR | 1 |
Carbonell, LF; Inglés, AC; Quesada, T; Ruiz, FJ; Salom, MG; Vicente, E | 1 |
Sun, HX; Yu, DJ; Yu, M; Zheng, Y | 1 |
1 review(s) available for acetylcysteine and enalaprilat anhydrous
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for acetylcysteine and enalaprilat anhydrous
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Captopril does not protect against renal oxidative injury.
Topics: Acetylcysteine; Animals; Captopril; Drug Interactions; Enalaprilat; Glutathione; Kidney; Lipid Peroxidation; Male; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Time Factors | 1992 |
Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor.
Topics: Acetylcholine; Acetylcysteine; Animals; Captopril; Cyclic GMP; Enalaprilat; Endothelium, Vascular; Glutathione; In Vitro Techniques; Nitric Oxide; Norepinephrine; Pyrogallol; Rabbits; Structure-Activity Relationship; Sulfhydryl Compounds; Superoxide Dismutase; Tiopronin; Vasodilation | 1991 |
Captopril-induced reversal of nitroglycerin tolerance: role of sulfhydryl group vs. ACE-inhibitory activity.
Topics: Acetylcholine; Acetylcysteine; Animals; Aorta; Captopril; Cyclic GMP; Drug Tolerance; Enalaprilat; Nitroglycerin; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Vasodilation | 1991 |
Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols.
Topics: Acetylcysteine; Blood Platelets; Captopril; Drug Synergism; Enalaprilat; Endothelium, Vascular; Humans; Iloprost; Nitric Oxide; Nitroprusside; Nucleotides, Cyclic; Platelet Aggregation Inhibitors; Sulfhydryl Compounds; Teprotide; Thrombin | 1991 |
N-acetyl-L-cysteine potentiates depressor response to captopril and enalaprilat in SHRs.
Topics: Acetylcysteine; Animals; Blood Pressure; Captopril; Drug Synergism; Enalaprilat; Hypertension; Male; Rats; Rats, Inbred SHR | 1994 |
Inhibitory effects of enalaprilat on rat cardiac fibroblast proliferation via ROS/P38MAPK/TGF-β1 signaling pathway.
Topics: Acetylcysteine; Active Transport, Cell Nucleus; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Enalaprilat; Fibroblasts; Gene Expression; Imidazoles; MAP Kinase Signaling System; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenols; Phosphorylation; Plant Extracts; Pyridines; Rats; Rats, Inbred WKY; Reactive Oxygen Species; Transforming Growth Factor beta1 | 2012 |